Skip to main content
. 2019 Jun 5;16:100107. doi: 10.1016/j.jctube.2019.100107

Table 1.

Population characteristics.

All (n: 143) Xpert-positive (n: 21) Xpert-negative (n: 122) P valueb
Site (n,%)
 - Maputo 50 11 (22.0%) 39 (78.0%) 0.070
 - Beira 93 10 (10.8%) 83 (89.2%)
Gender (n,%):
 - Male 74 12 (16.2%) 62 (83.8%) 0.592
 - Female 69 9 (13.0%) 60 (87.0%)
WHO HIV Clinical stage (n,%):
 - I 70 2 (2.9%) 68 (97.1%)
 - II 41 4 (9.8%) 37 (90.2%) <0.001
 - III 31 15 (48.4%) 16 (51.6%)
 - IV 1 0 (0%) 1(100.0%)
Age (years: median, IQR) (n: 143) 36 (29–43) 38 (31.5–44.5) 35.5 (29.0–43.0) 0.369
Time from HIV diagnosis (weeks: median, IQR) 2 (1–2) 2 (1–2) 2 (1–2) 0.474
Body mass index (Kg/m2: median, IQR)a 21.0 (19.1–24.3) 18.8 (17.4–20.6) 21.3 (19.3–24.8) <0.001
CD4 cell count, (cells/mm3, median, IQR) 194 (122–326) 133 (93–200) 202 (142–354) 0.012

  • Haemoglobin (g/dl, median, IQR)

 11.4 (10.1–13.1) 9.5 (8.9–11–3) 11.6 (10.4–13.2) 0.001

  • At least one WHO-4SS symptom (n,%)

 60 18 (30.0%) 42 (70.0%) <0.001

  • No WHO-4SS symptoms (n,%)

 83 3(3.6%) 80 (96.4%)
a

n: 142.

b

chi-square test for categorical variables; Mann–Whitney U test for quantitative variable.